Peramivir
Peramivir is an novel cyclopentane neuraminidase inhibitor of influenza virus. Peramivir has antiviral activity and anti-cytokines stom effects. Peramivir can be used for the research of COVID-19[1][2][3].
Product Specifications
CAS Number
330600-85-6
Product Name Alternative
RWJ-270201; BCX-1812
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
ERK; IKK; JNK; p38 MAPK; STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; MAPK/ERK Pathway; NF-κB; Stem Cell/Wnt
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/peramivir.html
Purity
99.94
Solubility
1 M HCl : 100 mg/mL|DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O[C@H]1[C@]([C@H](C(CC)CC)NC(C)=O)([H])[C@H](NC(N)=N)C[C@@H]1C(O)=O
Molecular Formula
C15H28N4O4
Molecular Weight
328.41
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
ERK1; ERK2; IKK-α; STAT3
Citation 01
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD13 / Aminopeptidase-N (Myeloid Cell Marker) (APN/1464), CF740 conjugate, 0.1mg/mL
